TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
XOMA

XOMA Royalty Corporation

Healthcare · Biotechnology

40.20$ +0.0% vs. previous close Closing price · As of: Jul 21, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow XOMA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-13.57 -5.24 -5.60 0.34 -1.51 -0.03 0.88 1.86 -1.13 -1.58 -1.17 0.16
0.32 0.26 0.13 0.04 0.00 0.00 0.00 0.00 0.01 0.08 0.02 0.17
1.87 1.65 1.27 0.91 0.47 0.56 0.34 0.51 0.32 0.79 0.88 0.52
-6.25 -2.21 -0.36 -0.56 0.46 0.56 0.34 0.53 0.32 – – –
-1.47 -0.20 3.29 -1.03 -0.36 -0.47 0.02 -0.07 -0.02 -0.31 -0.24 -0.63
0.06 0.07 0.01 0.00 1.79 2.20 0.11 2.17 2.04 0.00 0.00 1.15
3.41 0.76 0.10 0.20 -1.79 -2.20 -0.02 -2.17 -1.77 -0.06 -2.42 2.83
0.00 0.00 0.00 0.00 0.42 0.03 0.21 0.29 0.48 0.48 0.47 0.30
7.19 -0.01 0.01 -0.11 -0.03 -0.03 -0.21 -3.28 0.21 -0.01 0.00 -0.89
-1.03 2.26 -1.16 -2.06 0.87 0.98 -0.46 -1.75 0.00 11.33 -0.59 -0.59
6.17 2.34 -1.15 1.66 3.58 3.48 1.72 1.05 -0.39 10.51 -0.95 -1.47
-4.03 -2.15 -6.65 2.22 0.28 1.24 2.58 0.74 -3.29 8.87 -4.54 1.52
-13.63 -5.32 -5.61 0.34 -3.30 -2.23 0.77 -0.31 -3.17 -1.58 -1.18 0.16

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?